Skip to main content
OpenTrials

Clinical trial condition

Nasopharyngeal Carcinoma

Explore clinical trials studying Nasopharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.

237 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Nasopharyngeal Carcinoma trial results

Recruiting

Immune Score Based Radiomics in Nasopharyngeal Carcinoma

NCT05126160

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations
  • Renmin Hospital of Wuhan University Wuhan, Hubei, China
  • Ningbo First Hospital Ningbo, China
  • Ningbo Medical Center Lihuili Hospital Ningbo, China
  • The First Affiliated Hospital of Wenzhou Medical University Wenzhou, China
View Trial Details
Recruiting

Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients

NCT03353467

Conditions
Carcinoma, Endoscopic Surgery, Head and Neck Neoplasms, +14 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The First Affiliated Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China
  • The First People's Hospital of Foshan Guangzhou, Guangdong, China
  • Zhongshan People's Hospital Zhongshan, Guangdong, China
View Trial Details
Recruiting

Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

NCT04778956

Conditions
Carcinoma, Disease Attributes, Head and Neck Neoplasms, +17 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The First Affiliated Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • The Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View Trial Details
Recruiting

Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

NCT04453813

Conditions
Carcinoma, Chemotherapy, Head and Neck Neoplasms, +14 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Cancer Center of Guangzhou Medical University Guangzhou, Guangdong, China
  • Yuebei People's Hospital Shaoguan, Guangdong, China
  • Zhongshan People's Hospital Zhongshan, Guangdong, China
View Trial Details
Recruiting

Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma

NCT04448522

Conditions
Carcinoma, Chemotherapy, Head and Neck Neoplasms, +13 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Cancer Center of Guangzhou Medical University Guangzhou, Guangdong, China
  • Yuebei People's Hospital Shaoguan, Guangdong, China
  • Zhongshan People's Hospital Zhongshan, Guangdong, China
View Trial Details

Related conditions